Matthias Pinter

Research interests

Publications

• Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

  The Lancet · 2025 · https://doi.org/10.1016/s0140-6736(25)00403-9

• Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

  The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)01796-8

• Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

  Hepatology · 2022 · https://doi.org/10.1002/hep.32468

• Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.09.035

• NASH limits anti-tumour surveillance in immunotherapy-treated HCC

  Nature · 2021 · https://doi.org/10.1038/s41586-021-03362-0

• Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.10.004

• The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma

  JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2020.3381

• Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

  Gut · 2020 · https://doi.org/10.1136/gutjnl-2020-321702

• Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

  Science Translational Medicine · 2018 · https://doi.org/10.1126/scitranslmed.aag0945

• Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma

  Scientific Reports · 2018 · https://doi.org/10.1038/s41598-018-24437-5

• Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy

  Science Translational Medicine · 2017 · https://doi.org/10.1126/scitranslmed.aan5616

• Cancer and liver cirrhosis: implications on prognosis and management

  ESMO Open · 2016 · https://doi.org/10.1136/esmoopen-2016-000042

• Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy

  Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1177

• The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

  Hepatology · 2013 · https://doi.org/10.1002/hep.26256

• Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

  Gut · 2012 · https://doi.org/10.1136/gutjnl-2012-304038

• Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib

  Radiology · 2012 · https://doi.org/10.1148/radiol.12111550

Current projects

No projects listed.